BLCAP and urinary bladder carcinoma: Chen found that ADAR1 edits multiple sites in the YXXQ motif of BLCAP (a tumor suppressor for bladder cancer), causing it to lose its inhibition of STAT3 activation, thereby promoting tumorigenesis in cervical cancer (CC) (18).